Cancer Doctor Resigns From Sloan Kettering Over Financial Disclosure Controversy

This post was originally published on this site

Dr. José Baselga’s resignation comes as top officials at Memorial Sloan Kettering struggle to contain the fallout from an investigation into Baselga’s financial ties to companies like the Swiss drugmaker Roche and several small biotech startups. Meanwhile, the controversy shines a light on the need for transparency when it comes to experts who contribute to medical journals.